MC
SUPN icon

Menta Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Menta Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$259K Hold
7,824
– – 0.11% 335
2019
Q1 		$274K Hold
7,824
– – 0.12% 303
2018
Q4 		$260K Buy
7,824
+265
+4% +$11.4K 0.1% 340
2018
Q3 		$381K Sell
7,559
-184
-2% -$9.09K 0.13% 305
2018
Q2 		$463K Sell
7,743
-2,800
-27% -$145K 0.11% 353
2018
Q1 		$483K Sell
10,543
-72
-0.7% -$3K 0.1% 341
2017
Q4 		$423K Buy
10,615
+72
+0.7% +$2.85K 0.08% 400
2017
Q3 		$422K Sell
10,543
-1,700
-14% -$73.6K 0.06% 530
2017
Q2 		$528K Sell
12,243
-78,492
-87% -$2.79M 0.06% 515
2017
Q1 		$2.84M Sell
90,735
-59,981
-40% -$1.61M 0.28% 99
2016
Q4 		$3.81M Sell
150,716
-47,393
-24% -$1.06M 0.32% 59
2016
Q3 		$4.9M Buy
198,109
+71,029
+56% +$1.61M 0.47% 5
2016
Q2 		$2.59M Buy
127,080
+80,407
+172% +$1.43M 0.36% 24
2016
Q1 		$712K Sell
46,673
-19,192
-29% -$250K 0.1% 348
2015
Q4 		$885K Sell
65,865
-4,519
-6% -$69.9K 0.11% 301
2015
Q3 		$987K Sell
70,384
-64,145
-48% -$1.19M 0.16% 242
2015
Q2 		$2.28M Sell
134,529
-34,068
-20% -$485K 0.37% 48
2015
Q1 		$2.04M Buy
168,597
+75,196
+81% +$711K 0.26% 127
2014
Q4 		$775K Buy
+93,401
New +$785K 0.11% 310

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Menta Capital's SUPN Position: Q2 2019 in Review

Menta Capital held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2019 at 7,824 shares worth $259K. The position accounts for 0.11% of the portfolio, ranked #335.

Menta Capital first reported a position in SUPN in Q4 2014 and has held it in 19 quarters since. The position peaked at $4.9M in Q3 2016. 272 funds tracked by Wall St. Rank hold SUPN as of Q2 2019.

  • Menta Capital held 7,824 shares of Supernus Pharmaceuticals worth $259K as of Q2 2019.
  • Menta Capital left its Supernus Pharmaceuticals share count unchanged in Q2 2019.
  • Supernus Pharmaceuticals made up 0.11% of Menta Capital's portfolio in Q2 2019, its #335 holding.
  • Menta Capital first reported a position in Supernus Pharmaceuticals in Q4 2014 and has held it in 19 quarters since.
  • Menta Capital's Supernus Pharmaceuticals position peaked at $4.9M in Q3 2016.
  • 272 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.